## Active Patents
| Patent ID | Title | Date | Assignee |
|-----------|-------|------|----------|
| 11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index | 2024-01-23 | RedHill Biopharma Ltd. |
| 11872216 | Pharmaceutical formulation comprising cineole and amoxicillin | 2024-01-16 | ADVANCED SCIENTIFIC DEVELOPMENTS |
| 11813361 | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules | 2023-11-14 | PHARMAQUEST INTERNATIONAL CENTER, LLP |
| 10251843 | Crosslinked nanoparticle composition | 2019-04-09 | SAN HEH PHARMACEUTICAL CORPORATION |
| 10159647 | Tablet comprising crospovidone | 2018-12-25 | DSM Sinochem Pharmaceuticals Netherlands B.V. |
| 10004693 | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | 2018-06-26 | Flamel Ireland Limited |
| 9987257 | Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same | 2018-06-05 | Not specified |
| 9820943 | Micronized amoxicillin | 2017-11-21 | DSM Sinochem Pharmaceuticals Netherlands B.V. |
| 9814684 | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | 2017-11-14 | Flamel Ireland Limited |
| 9302012 | Anti-bacterial siderophore-aminopenicillin conjugates | 2016-04-05 | University of Notre Dame du Lac |
| 9254261 | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid | 2016-02-09 | SANDOZ AG |
| 8778924 | Modified release amoxicillin products | 2014-07-15 | SHIONOGI & CO., LTD. |
| 8715734 | Amoxicilline instant granulate | 2014-05-06 | SANDOZ AG |
| 7910133 | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin | 2011-03-22 | Flamel Technologies |
| 7807196 | Process for drying amoxicillin | 2010-10-05 | SANDOZ AG |
| 7759334 | Soluble forms of amoxicillin and treatment of animals | 2010-07-20 | Pharmaceutical Solutions, Inc. |
| 7534781 | Crystalline amoxicillin trihydrate powder | 2009-05-19 | DSM IP Assets B.V. |
| 7396527 | Antibiotic polymers | 2008-07-08 | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY |
| 7244720 | Soluble forms of amoxicillin and treatment of animals | 2007-07-17 | Pharmaceutical Solutions, Inc. |
| 7011849 | Second release phase formulation | 2006-03-14 | Beecham Pharmaceuticals (Pte) Limited |
| 6756057 | Amoxicillin and potassium clavulanate dosage form | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited |
| 6627222 | Amoxicillin-dicloxacillin antibiotic composition | 2003-09-30 | Advancis Pharmaceutical Corporation |
| 6103897 | Production of a crystalline salt of amoxicillin | 2000-08-15 | Biochemie Gesellschaft m.b.H |
| 5781170 | Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants | 1998-09-01 | Not specified |
| 5260292 | Topical treatment of acne with aminopenicillins | 1993-11-09 | Not specified |
| 4607029 | Novel sodium amoxicillin preparations | 1986-08-19 | Gist-Brocades N.V. |
| 4503040 | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors | 1985-03-05 | Pfizer Inc. |

Source: PatentsView API
Total found: 50

## FTO Risk Analysis
The analysis indicates several active patents and potential competitors in the field of amoxicillin formulations and treatments. The notable assignees include SANDOZ AG, Flamel Technologies, and Beecham Pharmaceuticals, indicating a competitive landscape. There are potential freedom-to-operate risks depending on the specific formulation and therapeutic claims being pursued by any new development involving amoxicillin.